PELATON is upregulated in the tissues and plasma of patients with inflammatory bowel disease and gastric cancer (96, 97) and may serve as a potential biomarker for assessing the incidence and prognosis of acute coronary syndrome (ACS) (98). This evidence concerns the gene PELATON and gastric cancer.